Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus

AIDS Research and Human Retroviruses

Volumn 16, Issue 11, 2000, Pages 1039-1045

  Berkowitz, R D ^a,b   Alexander, S ^a   McCune, J M ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; CYTOPATHOGENIC EFFECT; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; THYMOCYTE; THYMUS; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; THYMUS GLAND; VIRUS REPLICATION;

EID: 0034691651     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050075291     Document Type: Article

References (28)

1. 1. Berger EA, Doms RW, Fenyö EM, et al.: A new classification for HIV-1. Nature (London) 1998;391:240.
2. 2. Koot M, Keet IP, Vos AH, et al.: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-688.
3. 3. Richman DD and Bozzette SA: The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994;169:968-974.
4. 4. Bonyhadi ML, Rabin L, Salimi S, et al.: HIV induces thymus depletion in vivo. Nature (London) 1993;363:728-732.
5. 5. Stanley SK, McCune JM, Kaneshima H, et al.: Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993;178:1151-1163.
6. 6. Kaneshima H, Su L, Bonyhadi M, Conner R, Ho D, and McCune JM: Rapid-high, syncytium-inducing isolates of HIV directly induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol 1994;68:8188-8192.
7. 7. Su L, Kaneshima H, Bonyhadi M, et al.: HIV-1 induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 1995;2:25-36.
8. 8. Jamieson BD, Pang S, Aldrovandi GM, Zha J, and Zack JA: In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. J Virol 1995;69:6259-6264.
9. 9. Jamieson B, Uittenbogaart C, Schmid I, and Zack J: High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J Virol 1997;71:8245-8253.
10. 10. Jenkins M, Hanley MB, Moreno MB, Wieder E, and McCune JM: HIV-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo. Blood 1998;91:2672-2678.
11. 11. Berkowitz RD, Alexander S, Bare C, et al.: CCR5-and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. J Virol 1998;72: 10108-10117.
12. 12. Berkowitz RD, Beckerman KP, Schall TJ, and McCune JM: CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J Immunol 1998;161:3702-3710.
13. 13. Adachi A, Gendelman HE, Koenig S, et al.: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59:284-291.
14. 14. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, and Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986;233:215-219.
15. 15. Shacklett B, Denesvre C, Boson B, and Sonigo P: Features of the SIVmac transmembrane glycoprotein cytoplasmic domain that are important for Env functions. AIDS Res Hum Retroviruses 1998;14: 373-383.
16. 16. Toohey K, Wehrly K, Nishio J, Perryman S, and Chesebro B: Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 1995;213:70-79.
17. 17. Chesebro B, Wehrly K, Nishio J, and Perryman S: Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J Virol 1992;66:6547-6554.
18. 18. Penn ML, Grivel J-C, Schramm B, Goldsmith MA, and Margolis L: CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc Natl Acad Sci USA 1999;96:663-668.
19. 19. Doranz DJ, Rucker J, Yi Y, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
20. 20. Horuk R, Hesselgesser J, Zhou Y, et al.: The CC chemokine I-309 inhibits CCRS-dependent infection by diverse HIV-1 strains. J Biol Chem 1998;273:386-391.
21. 21. Reeves JD, McKnight A, Potempa S, et al.: CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 1997;231:130-134.
22. 22. Deng HK, Unutmaz D, KewalRamani VN, and Littman DR: Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature (London) 1997;388:296-300.
23. 23. Picchio GR, Gulizia RJ, Wehrly K, Chesebro B, and Mosier DE: The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. J Virol 1998;72: 2002-2009.
24. 24. Grivel J-C and Margolis LB: CCR5-and CXCR4-tropic HIV-1 are equally cytopathic for their targets in human lymphoid tissue. Nature Med 1999;5:344-346.
25. 25. Blaak H, van't Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, and Schuitemaker H: Differential infection of CD45RA+ and CD45RO+ CD4 T cells by syncytium inducing (SI) and non-syncytium inducing (NSI) HIV-1 variants. In: 6th Conference on Retroviruses and Opportunistic Infections, 1999. [Abstract]
26. 26. Scarlatti G, Tresoldi E, Bjorndal A, et al.: In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression. Nature Med 1997;3:1259-1265.
27. 27. Blaak H, Brouwer M, Ran LJ, de Wolf F, and Schuitemaker H: In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection. J Infect Dis 1998;177:600-610.
28. 28. Berkowitz RD, van't Wout AB, Kootstra NA, et al.: R5 strains of HIV-1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus. J Virol 1999;73:7817-7822.